Professor of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, New York; Medical Director, Recognition and Prevention Program, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York
Glen Oaks, New York
Christoph Correll, MD, is currently Professor of Psychiatry at Hofstra Northwell School of Medicine, New York, and Medical Director of the Recognition and Prevention program at the Zucker Hillside Hospital, New York. Dr. Correll completed his medical studies at both the Free University of Berlin in Germany, and at the Dundee University Medical School in Scotland. Dr. Correll is board-certified in both general psychiatry and child and adolescent psychiatry, having completed both residencies at The Zucker Hillside Hospital in New York City.
Dr. Correll’s research and clinical work focus on the identification, characterization, and psychopharmacological management of adults and youth with severe psychiatric disorders. His areas of expertise range from the prodrome and first episode to the refractory illness phase of patients with severe mood and psychotic disorders. His research further focuses on psychotropic medication efficacy, effectiveness, and adverse effects as well as on physical health in the mentally ill.
Dr. Correll has authored or co-authored over 450 journal articles. He has served on several expert consensus panels on the use of antipsychotics across a range of psychiatric disorders, is a reviewer for over 70 peer-reviewed journals, and serves as an editorial board member of 12 scientific journals. Dr. Correll is the Principal Investigator or Steering Committee member of several large, federally funded grants. He has received over 30 national and international research awards and fellowships for his work, and was listed consecutively for the last three years by Thomson Reuters since inception of this metric in 2014 as one of the “most influential scientific minds” and “top 1% cited scientists in the area of psychiatry.”
Sunday, October 6
9:00 AM – 10:15 AM